Icon

Gimoti - (15 mg/spray ; Metered Nasal Spray)

Metoclopramide Hydrochloride Evoke pharma
15 mg/spray ; Metered Nasal Spray
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
Less Than 5
None None
GIMOTI is a dopamine-2 (D2) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
Yes
***** ** **** *** ***, *.*. ****. **** ********* *** *********** ** * ****-*** ********* ** ***** ******* **** ***** (*****://**************.***-***.***/****-********/****-*******-*******/*****-*********-****-****-*******-*********-**-****-*******) ******* **** ******** **** *** ******* ** *******. *** ** ****** ****, **** *** ****** ** ******
Gimoti Patent 1 Patent 2
**** ********* ** **** *** ********* ** **** ***
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
**** *** / ********* *** **, **** ********* ** *** *** ********* ******** ** ** ****
  1. *** **, **** : * **** ** *** ***** *** ***** ** * *** *******.
  2. *** **, **** : **** ******** ***** ***** *** **** ** ******.
  3. *** *, **** : ***** **** **** ** ******* '***(*** **, ****) *** '*** (*** **, ****).
  4. *** **, **** : ***** ********* ********** ******* ****. ********* ** *****'* ***** *******, **** **** *** ***** ***** **** ******* *** ****-** ** * ****-*** ***********.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.